Infectious Disease Diagnostics Testing Market Size, Share, Growth, and Industry Analysis, By Types (Molecular Diagnostic Test, POC Infectious Disease Diagnostics Test), By Applications Covered (Hospital, Academics Research, Others), Regional Insights and Forecast to 2033

Detailed TOC of Global Infectious Disease Diagnostics Testing Market Insights, Forecast to 2033

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type, 2018 VS 2024 VS 2033
1.2.2 Molecular Diagnostic Test
1.2.3 POC Infectious Disease Diagnostics Test
1.3 Market by Application
1.3.1 Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Application, 2018 VS 2024 VS 2033
1.3.2 Hospital
1.3.3 Academics Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Diagnostics Testing Market Perspective (2018-2033)
2.2 Global Infectious Disease Diagnostics Testing Growth Trends by Region
2.2.1 Infectious Disease Diagnostics Testing Market Size by Region: 2018 VS 2024 VS 2033
2.2.2 Infectious Disease Diagnostics Testing Historic Market Size by Region (2018-2023)
2.2.3 Infectious Disease Diagnostics Testing Forecasted Market Size by Region (2024-2033)
2.3 Infectious Disease Diagnostics Testing Market Dynamics
2.3.1 Infectious Disease Diagnostics Testing Industry Trends
2.3.2 Infectious Disease Diagnostics Testing Market Drivers
2.3.3 Infectious Disease Diagnostics Testing Market Challenges
2.3.4 Infectious Disease Diagnostics Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Infectious Disease Diagnostics Testing by Players
3.1.1 Global Infectious Disease Diagnostics Testing Revenue by Players (2018-2023)
3.1.2 Global Infectious Disease Diagnostics Testing Revenue Market Share by Players (2018-2023)
3.2 Global Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Infectious Disease Diagnostics Testing, Ranking by Revenue, 2021 VS 2024 VS 2023
3.4 Global Infectious Disease Diagnostics Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Diagnostics Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostics Testing Revenue in 2024
3.5 Global Key Players of Infectious Disease Diagnostics Testing Head office and Area Served
3.6 Global Key Players of Infectious Disease Diagnostics Testing, Product and Application
3.7 Global Key Players of Infectious Disease Diagnostics Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Diagnostics Testing Breakdown Data by Type
4.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Type (2018-2023)
4.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2024-2033)
5 Infectious Disease Diagnostics Testing Breakdown Data by Application
5.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Application (2018-2023)
5.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Infectious Disease Diagnostics Testing Market Size (2018-2033)
6.2 North America Infectious Disease Diagnostics Testing Market Size by Type
6.2.1 North America Infectious Disease Diagnostics Testing Market Size by Type (2018-2023)
6.2.2 North America Infectious Disease Diagnostics Testing Market Size by Type (2024-2033)
6.2.3 North America Infectious Disease Diagnostics Testing Market Share by Type (2018-2033)
6.3 North America Infectious Disease Diagnostics Testing Market Size by Application
6.3.1 North America Infectious Disease Diagnostics Testing Market Size by Application (2018-2023)
6.3.2 North America Infectious Disease Diagnostics Testing Market Size by Application (2024-2033)
6.3.3 North America Infectious Disease Diagnostics Testing Market Share by Application (2018-2033)
6.4 North America Infectious Disease Diagnostics Testing Market Size by Country
6.4.1 North America Infectious Disease Diagnostics Testing Market Size by Country: 2018 VS 2024 VS 2033
6.4.2 North America Infectious Disease Diagnostics Testing Market Size by Country (2018-2023)
6.4.3 North America Infectious Disease Diagnostics Testing Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Infectious Disease Diagnostics Testing Market Size (2018-2033)
7.2 Europe Infectious Disease Diagnostics Testing Market Size by Type
7.2.1 Europe Infectious Disease Diagnostics Testing Market Size by Type (2018-2023)
7.2.2 Europe Infectious Disease Diagnostics Testing Market Size by Type (2024-2033)
7.2.3 Europe Infectious Disease Diagnostics Testing Market Share by Type (2018-2033)
7.3 Europe Infectious Disease Diagnostics Testing Market Size by Application
7.3.1 Europe Infectious Disease Diagnostics Testing Market Size by Application (2018-2023)
7.3.2 Europe Infectious Disease Diagnostics Testing Market Size by Application (2024-2033)
7.3.3 Europe Infectious Disease Diagnostics Testing Market Share by Application (2018-2033)
7.4 Europe Infectious Disease Diagnostics Testing Market Size by Country
7.4.1 Europe Infectious Disease Diagnostics Testing Market Size by Country: 2018 VS 2024 VS 2033
7.4.2 Europe Infectious Disease Diagnostics Testing Market Size by Country (2018-2023)
7.4.3 Europe Infectious Disease Diagnostics Testing Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Infectious Disease Diagnostics Testing Market Size (2018-2033)
8.2 China Infectious Disease Diagnostics Testing Market Size by Type
8.2.1 China Infectious Disease Diagnostics Testing Market Size by Type (2018-2023)
8.2.2 China Infectious Disease Diagnostics Testing Market Size by Type (2024-2033)
8.2.3 China Infectious Disease Diagnostics Testing Market Share by Type (2018-2033)
8.3 China Infectious Disease Diagnostics Testing Market Size by Application
8.3.1 China Infectious Disease Diagnostics Testing Market Size by Application (2018-2023)
8.3.2 China Infectious Disease Diagnostics Testing Market Size by Application (2024-2033)
8.3.3 China Infectious Disease Diagnostics Testing Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Infectious Disease Diagnostics Testing Market Size (2018-2033)
9.2 Asia Infectious Disease Diagnostics Testing Market Size by Type
9.2.1 Asia Infectious Disease Diagnostics Testing Market Size by Type (2018-2023)
9.2.2 Asia Infectious Disease Diagnostics Testing Market Size by Type (2024-2033)
9.2.3 Asia Infectious Disease Diagnostics Testing Market Share by Type (2018-2033)
9.3 Asia Infectious Disease Diagnostics Testing Market Size by Application
9.3.1 Asia Infectious Disease Diagnostics Testing Market Size by Application (2018-2023)
9.3.2 Asia Infectious Disease Diagnostics Testing Market Size by Application (2024-2033)
9.3.3 Asia Infectious Disease Diagnostics Testing Market Share by Application (2018-2033)
9.4 Asia Infectious Disease Diagnostics Testing Market Size by Region
9.4.1 Asia Infectious Disease Diagnostics Testing Market Size by Region: 2018 VS 2024 VS 2033
9.4.2 Asia Infectious Disease Diagnostics Testing Market Size by Region (2018-2023)
9.4.3 Asia Infectious Disease Diagnostics Testing Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country: 2018 VS 2024 VS 2033
10.4.2 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Infectious Disease Diagnostics Testing Introduction
11.1.4 Abbott Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.1.5 Abbott Recent Developments
11.2 bioM?rieux
11.2.1 bioM?rieux Company Details
11.2.2 bioM?rieux Business Overview
11.2.3 bioM?rieux Infectious Disease Diagnostics Testing Introduction
11.2.4 bioM?rieux Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.2.5 bioM?rieux Recent Developments
11.3 Diasorin
11.3.1 Diasorin Company Details
11.3.2 Diasorin Business Overview
11.3.3 Diasorin Infectious Disease Diagnostics Testing Introduction
11.3.4 Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.3.5 Diasorin Recent Developments
11.4 Roche Diagnostic
11.4.1 Roche Diagnostic Company Details
11.4.2 Roche Diagnostic Business Overview
11.4.3 Roche Diagnostic Infectious Disease Diagnostics Testing Introduction
11.4.4 Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.4.5 Roche Diagnostic Recent Developments
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Infectious Disease Diagnostics Testing Introduction
11.5.4 Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.5.5 Beckman Coulter Recent Developments
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Details
11.6.2 Becton, Dickinson and Company Business Overview
11.6.3 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Introduction
11.6.4 Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.6.5 Becton, Dickinson and Company Recent Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Developments
11.8 Cavidi
11.8.1 Cavidi Company Details
11.8.2 Cavidi Business Overview
11.8.3 Cavidi Infectious Disease Diagnostics Testing Introduction
11.8.4 Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.8.5 Cavidi Recent Developments
11.9 Cepheid
11.9.1 Cepheid Company Details
11.9.2 Cepheid Business Overview
11.9.3 Cepheid Infectious Disease Diagnostics Testing Introduction
11.9.4 Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.9.5 Cepheid Recent Developments
11.10 Corgenix
11.10.1 Corgenix Company Details
11.10.2 Corgenix Business Overview
11.10.3 Corgenix Infectious Disease Diagnostics Testing Introduction
11.10.4 Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.10.5 Corgenix Recent Developments
11.11 Diaxonhit
11.11.1 Diaxonhit Company Details
11.11.2 Diaxonhit Business Overview
11.11.3 Diaxonhit Infectious Disease Diagnostics Testing Introduction
11.11.4 Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.11.5 Diaxonhit Recent Developments
11.12 Eiken Chemical
11.12.1 Eiken Chemical Company Details
11.12.2 Eiken Chemical Business Overview
11.12.3 Eiken Chemical Infectious Disease Diagnostics Testing Introduction
11.12.4 Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.12.5 Eiken Chemical Recent Developments
11.13 EMD Millipore
11.13.1 EMD Millipore Company Details
11.13.2 EMD Millipore Business Overview
11.13.3 EMD Millipore Infectious Disease Diagnostics Testing Introduction
11.13.4 EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.13.5 EMD Millipore Recent Developments
11.14 Epitope Diagnostic
11.14.1 Epitope Diagnostic Company Details
11.14.2 Epitope Diagnostic Business Overview
11.14.3 Epitope Diagnostic Infectious Disease Diagnostics Testing Introduction
11.14.4 Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.14.5 Epitope Diagnostic Recent Developments
11.15 EUROIMMUN
11.15.1 EUROIMMUN Company Details
11.15.2 EUROIMMUN Business Overview
11.15.3 EUROIMMUN Infectious Disease Diagnostics Testing Introduction
11.15.4 EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.15.5 EUROIMMUN Recent Developments
11.16 Gold Standard Diagnostics
11.16.1 Gold Standard Diagnostics Company Details
11.16.2 Gold Standard Diagnostics Business Overview
11.16.3 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Introduction
11.16.4 Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.16.5 Gold Standard Diagnostics Recent Developments
11.17 Hologic
11.17.1 Hologic Company Details
11.17.2 Hologic Business Overview
11.17.3 Hologic Infectious Disease Diagnostics Testing Introduction
11.17.4 Hologic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.17.5 Hologic Recent Developments
11.18 Immunetics
11.18.1 Immunetics Company Details
11.18.2 Immunetics Business Overview
11.18.3 Immunetics Infectious Disease Diagnostics Testing Introduction
11.18.4 Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.18.5 Immunetics Recent Developments
11.19 InBios International
11.19.1 InBios International Company Details
11.19.2 InBios International Business Overview
11.19.3 InBios International Infectious Disease Diagnostics Testing Introduction
11.19.4 InBios International Revenue in Infectious Disease Diagnostics Testing Business (2018-2023)
11.19.5 InBios International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details